Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oral contraceptive displays cardioprotective effects

July 5, 1996

Ciba-Geigy introduces Noven's Vivelle in Canada

July 5, 1996

Memory impairment common side effect of GnRH agonist therapy

July 5, 1996

Ethical files PLA for estrogen/levonorgestrel patch in U.K.

July 5, 1996

U.S. clinical trials begin for Ethical Holdings' estradiol patch

July 5, 1996

Alteon describes new glucose-lowering agent

July 5, 1996

Nippon Chemiphar reports oral hypoglycemic agents for diabetes

July 5, 1996

Sankyo discloses sulfonamide derivatives for diabetes

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...